Lineage Cell Therapeutics

Lineage Cell Therapeutics is a clinical-stage biotechnology company focused on pioneering a new branch of medicine based on transplanting specific cell types to patients with serious medical conditions. Their proprietary cell-based therapy platform leverages their in-house manufacturing capabilities to develop and manufacture specialized, terminally-differentiated human cells from pluripotent and progenitor cell starting materials. These differentiated cells are designed to replace or support dysfunctional or absent cells due to degenerative disease or traumatic injury, or to help the body mount an effective immune response to cancer.

Lineage's programs are backed by an extensive IP portfolio and their subsidiary, CellCure Neurosciences, provides in-house cGMP manufacturing capabilities. They are currently working on several clinical programs, including OpRegen® for the treatment of geographic atrophy secondary to age-related macular degeneration and OPC1 for the treatment of severe spinal cord injury. Lineage is actively seeking partnerships to expand the reach of their cell therapies and bring their treatments to patients in need.

Lineage Cell Therapeutics does not mention any information about job flexibility on its website or in its job postings.

Lineage Cell Therapeutics offers competitive salaries and a comprehensive benefits package to its employees. This includes a challenging and motivating work environment where individuals are encouraged to be adaptable, accountable, engaged, collaborative, and creative. The company also prioritizes diversity and provides equal opportunities to all employees based on merit.

Lineage Cell Therapeutics is a clinical-stage biotechnology company focused on pioneering a new branch of medicine by developing novel cell therapies for patients with serious medical conditions. Their mission is to transplant specific cell types to replace or support dysfunctional or absent cells caused by degenerative diseases or traumatic injuries. They also develop cell therapies to help the body fight cancer by enhancing its immune response.

Lineage Cell Therapeutics fosters a culture of adaptability, accountability, collaboration, and creativity. They value employees who are willing to take initiative, work together effectively, and embrace new ideas. This is reflected in their statement that successful team members are "adaptable, accountable, engaged, collaborative, creative, and willing to roll up their sleeves to get any job done." They also prioritize diversity and inclusion within their workforce, creating an environment where individuals from various backgrounds can contribute their unique perspectives and experiences.

Lineage Cell Therapeutics is committed to fostering a diverse and inclusive workplace that values a blend of experiences, perspectives, skills, genders, ages, ethnicities, and cultural and social backgrounds at all levels, including the Board of Directors. They aim to provide equal opportunities to their workforce based on merit, and prohibit discrimination based on race, color, national origin, ancestry, citizenship status, religion, gender, sex, gender identity or expression, sexual orientation, age, marital status, pregnancy, physical or mental disability, genetic information, military service, medical condition, political affiliation, or other protected characteristics.